BlueFire to Continue DOE Funding Process for Biofuel Plant Construction

BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused on changing the world's transportation fuel paradigm through the production of ethanol from non-food cellulosic wastes, today announced that the Department of Energy has determined that BlueFire Ethanol has met the requirements necessary for Phase I of the application process and that the company has been invited to continue on to Phase II for the financing of their Fulton, MS Project.

The loan guarantee pursuant to this program would support the construction of BlueFire's commercial (cellulosic) biofuels plant planned in Fulton, MS. Under this program BlueFire has requested $250 million, which would be combined with the previously awarded $88 million dollar grant and other resources to provide sufficient capital for the project's construction and launch of the facility. The Fulton facility will produce 19 million gallons of ethanol per year from woody biomass, mill residue, and other cellulosic waste.

"We are very pleased to see the financing for the Fulton facility moving forward," said Arnold Klann, CEO of BlueFire Ethanol. "It's going to take programs like the DOE loan guarantee to enable first-of-its-kind technologies to be in a position to secure the necessary funding to move forward and help provide cleaner energy sources to the fuel market."

To help facilitate the closing of this financing, BlueFire Ethanol is actively recruiting specialists to close the transaction. "We are currently evaluating all options and seeking strategic personnel to help BlueFire successfully close the financing for the Fulton facility and other future facilities," says Klann.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.